Gene · 125
Papers2,710
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,710
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating multiomics sequencing analyses uncover the key mechanisms related to oxidative stress, mitochondria, and immune cells in keloid. | Gene | 2025 | 39489224 | PubTator, text mining | PubMed |
| Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis. | Hepatology | 2025 | 39058584 | PubTator, text mining | PubMed |
| Proliferative verrucous and homogeneous Leukoplakias exhibit differential methylation patterns. | Oral Dis | 2025 | 38852153 | PubTator, text mining | PubMed |
| Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase. | Mol Divers | 2025 | 38743308 | PubTator, text mining | PubMed |
| Alcohol Use Disorder Polygenic Score Compared With Family History and ADH1B. | JAMA Netw Open | 2024 | 39786404 | PubTator, text mining | PubMed |
| A Mendelian randomization study of alcohol use and cardiometabolic disease risk in a multi-ancestry population from the Million Veteran Program. | Alcohol Clin Exp Res (Hoboken) | 2024 | 39580711 | PubTator, text mining | PubMed |
| Identification of novel drug targets for liver cirrhosis and its potential side-effects by human plasma proteome. | Sci Rep | 2024 | 39572673 | PubTator, text mining | PubMed |
| Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer. | J Transl Med | 2024 | 39529035 | PubTator, text mining | PubMed |
| MR Corge: sensitivity analysis of Mendelian randomization based on the core gene hypothesis for polygenic exposures. | Bioinformatics | 2024 | 39513749 | PubTator, text mining | PubMed |
| Multiomics Reveals a Mechanism: Glycogen Synthesis, Galactose Metabolism, and Ethanol Degradation Pathways, the Durable Role of Neutralizing Antibodies in Preventing COVID-19. | ACS Omega | 2024 | 39464477 | PubTator, text mining | PubMed |
| Examining the causal association between moderate alcohol consumption and cardiovascular risk factors in the Taiwan Biobank: a Mendelian randomization analysis. | Front Cardiovasc Med | 2024 | 39416436 | PubTator, text mining | PubMed |
| Transgenic expression of human cytochrome P450 2E1 in C. elegans and rat PC-12 cells sensitizes to ethanol-induced locomotor and mitochondrial effects. | Biochem Biophys Res Commun | 2024 | 39357336 | PubTator, text mining | PubMed |
| Addressing the credibility crisis in Mendelian randomization. | BMC Med | 2024 | 39256834 | PubTator, text mining | PubMed |
| A Compound Containing Aldehyde Dehydrogenase Relieves the Effects of Alcohol Consumption and Hangover Symptoms in Healthy Men: An Open-Labeled Comparative Study. | Pharmaceuticals (Basel) | 2024 | 39204192 | PubTator, text mining | PubMed |
| Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula's mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation. | Transl Cancer Res | 2024 | 39145086 | PubTator, text mining | PubMed |
| Adipocytes impact on gastric cancer progression: Prognostic insights and molecular features. | World J Gastrointest Oncol | 2024 | 39072151 | PubTator, text mining | PubMed |
| Rare and common variants associated with alcohol consumption identify a conserved molecular network. | Alcohol Clin Exp Res (Hoboken) | 2024 | 39031522 | PubTator, text mining | PubMed |
| Integrating molecular pathway with genome-wide association data for causality identification in breast cancer. | Discov Oncol | 2024 | 38954227 | PubTator, text mining | PubMed |
| Use of Mendelian randomization to assess the causal status of modifiable exposures for rheumatic diseases. | Best Pract Res Clin Rheumatol | 2024 | 38951047 | PubTator, text mining | PubMed |
| Global Gene Expression Profiling and Bioinformatics Analysis Reveal Downregulated Biomarkers as Potential Indicators for Hepatocellular Carcinoma. | ACS Omega | 2024 | 38911766 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/125/papers?page=7